SB2858 - Health benefit plans; set provisions related to diagnostic breast exams and individualized investigational drugs.

3 Co-Sponsors

An Act To Provide That A Manufacturer May Make An Individualized Investigative Treatment, And An Eligible Patient Who Has A Life-threatening Or Severely Debilitating Illness May Receive Such Treatment If The Patient Has Given Written, Informed Consent; To Provide That A Health Plan, Third Party Administrator, Or Governmental Agency May Provide Coverage For The Cost Of An Individualized Investigational Drug, Biological Product, Or Device, Or The Cost Of Services Related To The Use Of An Individualized Investigational Drug, Or Biological Product; To Prohibit A Licensing Board Or Disciplinary Subcommittee From Revoking, Failing To Renew, Suspending, Or Taking Any Action Against A Health Care Provider's License Based Solely On The Health Care Provider's Recommendations To An Eligible Patient Regarding Access To Or Treatment With An Individualized Investigational Drug; To Set Certain Provisions Related To Civil Causes Of Action And Liability Related To The Act; To Prohibit An Official, Employee, Or Agent Of This State From Blocking Or Attempting To Block An Eligible Patient's Access To An Individualized Investigational Drug, Biological Product, Or Device; To Provide For The Severability Of The Act; To Bring Forward Section 41-41-3, Mississippi Code Of 1972, For The Purpose Of Possible Amendment; To Prohibit Group Health Plans And Health Insurance Issuers That Provide Benefits With Respect To Screening, Diagnostic Breast Examinations And Supplemental Breast Examinations Furnished To Individuals Enrolled Under Such Plans From Imposing Any Cost-sharing Requirements For Those Services; To Amend Section 83-9-108, Mississippi Code Of 1972, To Conform To The Preceding Provisions; And For Related Purposes.